Skip to main content
. 2018 Autumn;9(4):334–340. doi: 10.22088/cjim.9.4.334

Table 1.

Comparison of basal characteristics between severe dengue and non-severe dengue

Severe dengue
(includes deaths)
(n=117)
Non-severe dengue
(n=217)
Total P value
Men 66(56.4%) 120(55.2%) 186 (55.6%) 0.8
Women 51(43.5%) 97(44.7%) 148 (44.4%) 0.8
Mean age (years) 30.4±11.8 30.3±15.4 30.3±14.3 0.9
Hypertensive 15(12.8%) 18(8.2%) 33 (9.8%) 0.4
Diabetes 45(38.4%) 37(17%) 82 (24.5%) 0.001
Delay in admission (>5days ) 43(36.7%) 31(14.2%) 74 (22.1%) 0.0001
Low platelet count(<50,000 mm3) 69(58.9%) 23(10.5%) 92 (28.7%) 0.0001
Chills 79(67.5%) 170(78.3%) 249 (74.5%) 0.1
Headache 51(43.5%) 76(35%) 127 (38%) 0.0001
Myalgia 97(82.9%) 197(90.7%) 294 (88%) 0.5
Arthralgia 49(41.8%) 63(29.8%) 112 (33.5%) 0.09
Melena 40(34.1%) 33(15.2%) 73 (21.8%) 0.0001
Rashes 53(45.2%) 50(23%) 103 (30.8%) 0.0001
Nausea and vomiting 82(70%) 137(63.1%) 219 (65.5%) 0.6
Abdominal Pain 71(60.6%) 110(50.6%) 181 (54%) 0.1
Lymphadenopathy 27(23%) 13(5.9%) 40 (11.9%) 0.0001
Fever >390C 48(41%) 92(42.3%) 140 (41.9%) 0.8
Elevated hematocrit (>40%) 76(64.9%) 61(28.1%) 137 (41%) 0.0001
Hypotension 18(15.3%) 20(9.2%) 38 (11.3%) 0.1
Bradycardia 12(10.2%) 0 12 (3.5%) 0.0001
Elevated Plasma Thromboplastin Time (>1.5) 58(49.5%) 67(30.8%) 125 (37.4%) 003
Splenomegaly 22(18.8%) 0 22 (6.5%) 0.0001
Convulsions 14(11.9%) 0 14 (4.1%) 0.02
Hepatomegaly 26(22.2%) 0 26 (7.7%) 0.0001
Deaths 5(4.2%) 0 5 (1.4%) 0.02